Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

ReproCELL

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 2
Average round size
info
The average size of a deal this fund participated in
$8M
Portfolio companies 2
Rounds per year 0.11
Lead investments 0
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Business Intelligence
  • Pharmaceutical
Summary

ReproCELL appeared to be the Corporate Investor, which was created in 2003. The fund was located in Asia if to be more exact in Japan. The leading representative office of defined Corporate Investor is situated in the Yokohama.

The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2019.

Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Business Intelligence, Health Care. Among the most popular portfolio startups of the fund, we may highlight Symic Biomedical.

The typical case for the fund is to invest in rounds with 5 participants. Despite the ReproCELL, startups are often financed by Zenyaku Kogyo, Nissei Capital, Nippon Venture Capital. The meaningful sponsors for the fund in investment in the same round are Zenyaku Kogyo, Shinsei Bank, Keio Innovation Initiative. In the next rounds fund is usually obtained by Tohoku University Venture Partners.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of ReproCELL:
Typical Co-investors
ReproCELL is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after ReproCELL:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Apollo Investment Corporation New York, New York, United States
Bonneville Power Administration Oregon, Portland, United States
Daimler Baden-Wurttemberg, Germany, Stuttgart
Hivers and Strivers -
Licheng Fuyi Touzi Baoshan, China, Shanghai
LOI Labs British Columbia, Canada, Vancouver
Maroc Numeric Fund Casablanca, Grand Casablanca, Morocco
Maryland Health Care Product Development Maryland, Rockville, United States
MegaDelta Capital -
Nest Collective Foundation -
NSV Wolf Capital California, Menlo Park, United States
PacRim Venture Partners California, Menlo Park, United States
Positive Ventures Brazil, São Paulo, São Paulo
Relentless Pursuit Partners British Columbia, Canada, Vancouver
Sauzalito Ventures California, Sausalito, United States
Tasly Holding Group China, Guangdong, Tianjin
TRANSSION China, Guangdong, Shenzhen
Tronfund China, Huangpu, Shanghai
UTIMCO Austin, Texas, United States
Zhuoyuan Capital China, Guangdong, Shenzhen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Symic Biomedical

Biotechnology
Business Intelligence
Health Care
$11M25 Apr 2019 California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent ReproCELL?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 2
Average round size 8M
Rounds per year 0.11
Peak activity year 2016
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Symic Biomedical

Biotechnology
Business Intelligence
Health Care
$11M25 Apr 2019 California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: